A detailed history of Plato Investment Management LTD transactions in Veracyte, Inc. stock. As of the latest transaction made, Plato Investment Management LTD holds 904 shares of VCYT stock, worth $29,687. This represents 0.0% of its overall portfolio holdings.

Number of Shares
904
Previous 904 -0.0%
Holding current value
$29,687
Previous $20 Million 2.21%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$21.0 - $29.1 $14,700 - $20,370
700 Added 343.14%
904 $30.7 Million
Q4 2023

Feb 12, 2024

BUY
$19.72 - $28.68 $4,022 - $5,850
204 New
204 $5.61 Million

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.35B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Plato Investment Management LTD Portfolio

Follow Plato Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plato Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Plato Investment Management LTD with notifications on news.